KEQU

Business Context and Reporting Period

Company: Kewaunee Scientific Corporation
Filing Type: Form 10-K (Annual Report)
Period Ended: April 30, 2011
Business Overview: The Company designs, manufactures, and installs laboratory, technical, and laminate furniture products. Operations are divided into Domestic and International segments. Products are sold primarily to pharmaceutical, biotechnology, educational, healthcare, and governmental entities. The Company is a smaller reporting company with a significant portion of business derived from competitive public bidding.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue: Net sales increased 1% to $100.0 million. This was driven by a 38% increase in International Operations sales ($15.9 million), which offset a 4% decline in Domestic Operations sales ($84.1 million) due to an economic slowdown affecting small and mid-sized projects.
• Profitability: Net earnings attributable to the Company declined 48% to $1.9 million. Gross margin compressed from 21.6% to 19.3% due to increased competitive pricing and higher raw material costs (steel and epoxy resin).
• Expenses: Operating expenses rose to $16.1 million (16.1% of sales) from $15.6 million. Increases were attributed to expanded international operations, sales and marketing, depreciation, and stock option expenses, partially offset by lower pension and bad debt expenses.
• Debt: Total borrowings increased significantly to $10.6 million from $5.1 million. This included a new $4 million seven-year term loan secured by real property and equipment, alongside increased utilization of the revolving credit facility ($6.6 million outstanding).
• Cash Flow: Operating cash flow decreased to $1.3 million from $4.5 million, primarily due to increases in accounts receivable and inventory. Capital expenditures increased to $5.2 million, funded largely by long-term debt.

Guidance, Outlook, and Risks

Outlook: Management expects fiscal year 2012 to be profitable. Capital expenditures for 2012 are anticipated to be approximately $1.5 million, primarily for manufacturing equipment, funded by operating activities and credit facility borrowings.

Key Risks and Contingencies:

• Economic Conditions: Volatility in financial markets and economic recessions could materially adversely affect demand for laboratory construction projects.
• Raw Material Costs: The Company bears the burden of increases in labor and material costs (steel, wood, epoxy resin) between order quotation and delivery, as prices are typically quoted on a firm basis.
• Customer Concentration: Sales to one national distributor, VWR International, LLC, represented approximately 14% of net sales in fiscal 2011.
• Project Delays: Revenue recognition is subject to delays in building construction projects, which may cause shipments to occur in different quarters than anticipated.
• Interest Rate Risk: The Company has exposure to floating interest rates on its revolving credit facility, though it has utilized interest rate swaps to fix rates on specific portions of its debt.

Investor Verification Checklist

• Verify the sustainability of the 38% growth in International Operations and the extent of the recovery in the global laboratory furniture market.
• Monitor raw material price trends (specifically steel and epoxy resin) and the Company's ability to pass these costs to customers without losing competitive bids.
• Assess the impact of the increased debt load ($10.6 million total) on future interest expenses and liquidity, particularly given the $6.6 million draw on the revolving credit facility.
• Review the order backlog of $65.7 million and the estimated 70% shipment rate for fiscal 2012 to gauge near-term revenue visibility.
• Confirm the status of the $4 million term loan covenants and the Company's compliance with financial ratios (debt-to-net worth, fixed charge coverage).